Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)- Insider Own34.39% Shs Outstand38.67M Perf Week2.15%
Market Cap607.51M Forward P/E- EPS next Y- Insider Trans25.08% Shs Float25.37M Perf Month-
Income- PEG- EPS next Q-1.47 Inst Own27.49% Short Float / Ratio1.70% / 1.39 Perf Quarter-
Sales- P/S- EPS this Y- Inst Trans- Short Interest0.43M Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Target Price28.33 Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range13.14 - 17.29 Perf YTD8.12%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-9.14% Beta-
Dividend %- Quick Ratio- Sales past 5Y0.00% Gross Margin- 52W Low19.56% ATR1.00
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)- Volatility8.49% -
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.36 Prev Close15.64
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume308.66K Price15.71
Recom1.00 SMA204.83% SMA504.83% SMA2004.83% Volume111,701 Change0.45%
Date Action Analyst Rating Change Price Target Change
Dec-05-23Initiated Truist Buy $34
Dec-05-23Initiated TD Cowen Outperform
Dec-05-23Initiated JP Morgan Overweight $23
Dec-05-23Initiated Jefferies Buy $28
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Mateo, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Third Rock Ventures V, L.P.10% OwnerNov 14Buy15.001,333,33319,999,9951,807,119Nov 14 07:08 PM
PERCEPTIVE ADVISORS LLCFormer 10% OwnerNov 14Buy15.00666,6669,999,9902,912,835Nov 14 04:32 PM
Samsara BioCapital GP, LLC10% OwnerNov 14Buy15.00666,6669,999,9904,121,689Nov 16 07:39 PM